Medical Waste Generation during COVID-19 (SARS-CoV-2) Pandemic and Its Management: An Indian Perspective
Asian Journal of Environment & Ecology,
Page 10-15
DOI:
10.9734/ajee/2020/v13i130171
Abstract
The generation of biomedical waste has increased many times after the SARS Cov2 commencement. The biomedical waste generated from COVID-19 Patients is very infectious and contaminated. Thus, it is a big challenge with all stakeholders to avoid spreading of COVID-19 through it. This requires monitoring the complete cycle to the grave to be monitored from the cradle, if the spreading needs to be controlled. The COVID-19 waste generation, collection, storage, transportation and disposal is a big challenge withall stakeholders including isolation wards, quarantine centres, sample collection centres, laboratories, urban local bodies, and the Common Bio-medical Waste Treatment Facility (CBWTF) respectively. As its a novel virus and WHO has instructed that proper guidelines need to be followed with regards to COVID-19biomedical waste generation and its safe disposal. The Government of India has separately developed the Guidelines for the handling of COVID-19 biomedical waste, which needs to be followed besides BiomedicalRules, 2016 so that Corona spread through this can be controlled. Owing to its novel origin and least information about its behaviour, thus it is extremely important to take all precautions possible till we get some medical treatment.
Keywords:
- SARS-CoV-2
- COVID-19
- biomedical waste
- treatment
- disposal
How to Cite
References
DOI:https://doi.org/10.1016/S0140-6736(20)30211-7
Holshue ML, De Bolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, WilkersonS,Tural A, Diaz G, Cohn A, Fox Le A, Patel A, Gerber SI, Kim L, Tong S, Lu X, Lindstrom S, Pallansch M A, Weldon WC, Biggs HM, Uyeki TM, Satish K, Pillai SK. First case of 2019 novel coronavirus in the United States. The New England J Med. 2020;5;382(10):929-936.
DOI: 10.1056/NEJMoa2001191
WHO. Water, Sanitation, Hygiene and waste management for the COVID-19 Virus. WHO and UNICEF. Interim Guidance, WHO/2019-nCoV/IPC_WASH/2020.2. 2020;1-6.
Asian Development Bank. Managing Infectious medical Waste during the COVID-19 Pandemic; 2020.
Available:http://www.adb.org
Available:https://www.theverge.com/2020/3/26/21194647/the-COVID-19-pandemic-is-generating-tons-of-medical-waste
Available:https://www.latimes.com/environment/story/2020-03-30/medical-waste-industry-coronavirus-contaminated-trash
Doremalen NV, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, Wit E de, Munster VJ. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1, The New England J Med. 2020; 382:1564-1567.
DOI:10.1056/NEJMc2004973
Chin AWH, Chu JTS, Perera MRA, Hui KPY, Yen Hui-Ling, Chan MCW, Peiris Malik, Poon LLM, Chu JTS. Stability of SARS-CoV-2 in different environmental conditions. The Lancet Microbe. 2020;1 (1):E10.
DOI:https://doi.org/10.1016/S2666-5247(20)30003-3
CPCB Guidelines.
Available:https://www.cpcb.nic.in/uploads/Projects/Bio-Medical-Waste/BMW-GUIDELINES-COVID.pdf
-
Abstract View: 3464 times
PDF Download: 1717 times